On a standard FDG PET/CT scan, a healthy adult liver typically shows a mean SUV (standardized uptake value) somewhere in the range of roughly 1.5 to 3.0, depending on how the measurement is taken, which scanner is used, and a handful of patient-specific factors. Studies in healthy adults have reported mean liver SUV values around 1.8 to 2.2 when normalized to body weight, with maximum values running higher. But that range is deceptively simple, because “normal” liver SUV shifts with your blood sugar, your body composition, your age, and whether your liver is truly healthy or quietly harboring fat or scar tissue. Understanding what moves these numbers matters, because the liver is the single most important internal reference organ on a PET scan.
Why the Liver Is the Yardstick on a PET Scan
Radiologists do not just look at liver SUV to evaluate the liver itself. The liver serves as the internal benchmark against which suspicious findings elsewhere in the body are judged. In lymphoma staging, for example, the widely used Deauville scoring system compares the tracer uptake in a residual tumor to the uptake in normal liver tissue. If the tumor lights up less than the liver, it is generally scored as a good response; if it lights up more, concern rises. A quantitative extension of this scoring system, called qPET, divides the peak uptake in a residual lymphoma by the mean liver SUV measured in a standardized 30-milliliter volume, producing a ratio that helps predict outcomes more consistently than eyeballing alone.1Journal of Nuclear Medicine. Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET–Based Response Assessment: Data from the EuroNet-PHL-C1 Trial A similar concept drives the PERCIST criteria for solid tumors, where changes in a lean-body-mass-corrected SUV (called SUL) are tracked over time, with the liver again providing the metabolic backdrop.2PubMed Central. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
The liver earns this role because its FDG uptake is relatively stable across most of the organ and relatively predictable from one scan to the next. In one study of healthy volunteers, the reproducibility of mean liver SUV was about 6.7%, meaning that if you scanned the same person twice under the same conditions, the values would land within a few percentage points of each other.3PubMed. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans That is good enough to make it a useful reference, but not so ironclad that you can ignore the variables that push it around.
How Blood Sugar Moves the Number
FDG is a glucose analog. Wherever glucose is being actively consumed, FDG accumulates. The liver is one of the body’s central hubs for glucose processing, so its FDG uptake is sensitive to what your blood sugar is doing at the time of the scan. A systematic review pooling evidence across multiple studies found a consistent positive association between blood glucose and liver SUV: higher blood sugar means higher liver uptake.4PubMed Central. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review The magnitude of this effect is generally small under normal fasting conditions, but it becomes more pronounced with elevated glucose levels.
A large meta-analysis covering over 20,000 individual SUV measurements confirmed this pattern and added a practical threshold: if your blood glucose is below 200 mg/dL, the bump in liver SUV is usually not large enough to warrant intervention before scanning, unless the liver itself is the organ being evaluated.5PubMed. Effect of blood glucose level on standardized uptake value (SUV) in (18)F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements At higher glucose levels, particularly in patients with diabetes, the effect can genuinely distort the liver’s role as a reference. One study found that elevated glucose increased liver FDG uptake especially on delayed imaging, reflecting the liver’s role in glycogen storage and gluconeogenesis.6PubMed. Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study
This is why PET centers insist on fasting before a scan, typically for at least four to six hours. The goal is a blood sugar level below about 150 to 200 mg/dL. If your glucose is well above that range, some facilities will reschedule or administer insulin and wait, though this introduces its own complications because insulin drives FDG into muscle and fat, pulling it away from tumors.
Body Weight and the Obesity Problem
Standard SUV is calculated using the patient’s body weight. The math is straightforward: the tracer concentration in a region gets multiplied by the patient’s weight and divided by the injected dose. The trouble is that fat tissue takes up very little FDG, so in a heavier person, the weight-based correction overcorrects. The result is an artificially inflated SUV everywhere, including the liver. One study found that liver SUVmean was 33 to 36 percent higher in obese patients compared to people with a normal BMI, and SUVmax was 36 to 41 percent higher.7Journal of Nuclear Medicine Technology. Revisiting Weight-Normalized SUV and Lean-Body-Mass–Normalized SUV in PET Studies That is not a trivial shift if you are trying to use the liver as a stable reference.
To fix this, many centers now report SUL, which substitutes lean body mass for total body weight in the calculation. When lean-body-mass normalization was applied, the difference between obese and normal-weight patients essentially disappeared for liver and blood pool measurements.7Journal of Nuclear Medicine Technology. Revisiting Weight-Normalized SUV and Lean-Body-Mass–Normalized SUV in PET Studies The catch is which lean-body-mass formula the scanner uses. The older James formula breaks down in very obese women, producing erroneously low SUL values. The Janmahasatian formula handles this better and is now recommended for modern PET scanners, particularly given rising obesity rates.8Journal of Nuclear Medicine. Optimum lean body formulation for correction of standardized uptake value in PET imaging If your PET report shows SUL instead of or alongside SUV, this lean-mass correction is the reason.
Age and Sex
Liver SUV creeps upward with age. A large retrospective study of over 2,500 subjects found that age was the strongest predictor of liver SUV, with values rising rapidly through childhood and adolescence, then continuing a slow upward drift throughout adulthood without reaching a clear plateau.9PubMed Central. Age-related changes of standardized uptake values in the blood pool and liver: a decade-long retrospective study of the outcomes of 2,526 subjects A separate study confirmed that age was a statistically significant predictor of both liver SUVmax and SUVmean, while sex, hepatitis B status, and hepatitis C status were not.10PubMed. Impact of age on FDG uptake in the liver on PET scan
Sex on its own does not appear to change raw liver SUV much. Where it does show up is in the choice of normalization metric. When SUV is adjusted for lean body mass (SUL), values tend to be slightly higher in men than in women, while surface-area-based corrections can flip that relationship.11PubMed Central. The appropriate whole body metric for calculating standardised uptake value and the influence of sex In practice, the sex difference is small enough that most centers do not apply sex-specific reference ranges, though researchers continue to debate whether they should.
What Fatty Liver Does to Liver SUV
Given how common fatty liver disease has become, this is a question with real clinical weight. The short answer is that hepatic steatosis pulls liver FDG uptake in somewhat contradictory directions depending on the study and the normalization method, but the overall effect appears to be modest.
One study found that patients with steatosis had slightly lower lean-body-mass-corrected liver SUV compared to healthy controls, but concluded that the decrease was small enough to be clinically insignificant for the liver’s role as an internal reference organ.12PubMed. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT Another found a statistically significant negative correlation between the severity of fatty liver (graded by ultrasound) and liver SUVmax, meaning that worse steatosis tracked with lower FDG uptake after adjusting for age, sex, and BMI.13PubMed. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET Yet a third study, in a different patient population, found the opposite direction: significantly higher SUVmean and SUVmax in the fatty liver group.14PubMed Central. The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
The discrepancy likely reflects differences in how patients were matched, what other metabolic conditions they had (especially obesity and diabetes), and whether SUV was corrected for lean body mass or raw body weight. In an obese patient with fatty liver, the weight-based SUV may look high because of the body-weight inflation described earlier, while the underlying metabolic activity of the steatotic liver cells is actually somewhat reduced. What matters for you as a patient is this: if you have known fatty liver disease, your radiologist should be aware of it when interpreting your scan, because it can subtly shift the reference point against which other findings are judged. Lymphoma researchers have specifically investigated how steatosis affects the Deauville score, since a drop in liver reference uptake could make a residual tumor look relatively hotter than it truly is.15PubMed Central. Assessment of alteration in liver (18)F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
Cirrhosis and Reduced Liver Metabolism
Cirrhosis pushes liver FDG uptake in a clearer direction than steatosis: downward. In a pilot study comparing patients with cirrhosis to non-cirrhotic controls, the cirrhotic group had a significantly lower average liver SUVmean (about 1.55 versus 1.81), reflecting reduced overall hepatic glucose metabolism.16PubMed. Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study This makes biological sense: a cirrhotic liver has fewer functioning hepatocytes and more scar tissue, so there is simply less metabolically active tissue to take up glucose or its analogs.
The implications go beyond FDG. A study using a different tracer, 68Ga-FAPI, found that cirrhotic livers had markedly higher uptake of that fibrosis-targeted tracer compared to non-cirrhotic livers, with a median SUVavg of 1.42 versus 0.45.17PubMed. Influence of Cirrhosis on (68)Ga-FAPI PET/CT in Intrahepatic Tumors This is a different tracer measuring a different biological process (fibroblast activation rather than glucose metabolism), but it underscores a broader point: the “normal” liver SUV depends entirely on which tracer you are talking about, and cirrhosis pushes different tracers in opposite directions.
Chemotherapy Changes the Baseline
If you are undergoing cancer treatment and getting serial PET scans, be aware that chemotherapy itself can shift the liver’s background uptake. A study of lymphoma patients treated with R-CHOP found that liver SUVmean and SUVmax both increased significantly after just one week of therapy and stayed elevated through the end of treatment.18PubMed. The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy Another study measured roughly a 12 percent rise in liver SUVmean after chemotherapy.19PubMed. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
The mechanism is likely multifactorial. Chemotherapy can cause liver inflammation, alter glycogen metabolism, and affect blood flow patterns. Whatever the cause, this mid-treatment shift matters because the whole point of serial PET scanning during treatment is to measure whether tumor uptake is falling. If the liver reference is simultaneously rising, a tumor that looks like it is keeping pace with the liver may actually be responding well. Experienced nuclear medicine physicians account for this, but it is worth knowing that the goalposts can move.
Scanner and Technical Variability
Not all PET scanners produce the same numbers. Differences in detector crystals, time-of-flight capability, reconstruction algorithms, and the matrix size chosen during image processing can shift SUV measurements by a meaningful margin. Phantom studies have documented at least a 12 percent difference in measured SUV depending on reconstruction settings alone.20Medical Research Archives. The use of the optimized standard uptake value – SUVopt – in the interpretation of FDG PET-CT IN Adrenal Gland and Pleural Based Malignancy Even within scanners accredited under the same quality program, one large comparison between conventional and digital PET systems found average SUV differences of 6 to 8 percent, with repeatability coefficients (the range within which repeat measurements would fall) of 27 to 33 percent for individual lesions.21PubMed Central. SUV variability in EARL-accredited conventional and digital PET
When comparing PET/CT to PET/MRI, liver SUV measurements showed no statistically significant difference, though tumor lesion values were underestimated on PET/MRI, and the correlation for liver SUV and SUL metrics between the two modalities was moderate.22Frontiers in Medicine. Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT Intravenous contrast agent, sometimes given during a PET/CT to improve anatomical detail, does not appear to significantly change liver SUV measurements.23PubMed. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT
Breathing introduces another layer of noise. The liver sits right below the diaphragm and moves with every breath. Because a PET scan collects data over minutes while CT captures a near-instantaneous snapshot, the two can disagree about where the liver dome actually is. On CT-corrected images, nearly 70 percent of scans showed an artifactual cold area in the upper liver caused by this respiratory mismatch.24PubMed. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source For most of the liver, this does not affect SUV measurements. But for lesions sitting right at the dome, it can falsely lower their apparent uptake and, in a small number of cases, affect the ability to detect them altogether.
Liver SUV in Children
Pediatric patients deserve special mention because their liver SUV values sit well below adult norms. One study measured a mean liver SUV of about 1.1 in children, compared to about 1.9 in adults at the same center, both using body-weight normalization.25PubMed. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter Children’s bodies are changing rapidly in composition, and the proportion of metabolically active tissue to body weight is different from adults. Body-surface-area normalization turned out to produce more uniform SUV measurements across different ages in children, making it a better choice for follow-up scans in pediatric oncology. If your child is being monitored with PET scans, the radiologist should be using age-appropriate reference values rather than adult ranges.
How Liver SUV Differs With Non-FDG Tracers
Everything discussed so far applies to FDG, the sugar-based tracer used in the vast majority of oncologic PET scans. Other tracers behave very differently in the liver. With 68Ga-DOTATATE, a tracer used to image neuroendocrine tumors, the normal liver shows a much higher SUVmean of around 5.0, compared to about 1.0 in the blood pool and 17 in the spleen.26Journal of Nuclear Medicine. Normal biodistribution and tumor uptake of 68Ga DOTATATE PET / CT in the clinical setting: normal background activity, and organ specific tumor characterization of metastatic lesions If you have had a DOTATATE scan and see a liver SUV of 5, that is entirely normal for that tracer and should not be compared to FDG reference values.
The underlying biology explains the discrepancy. FDG traces glucose metabolism, and the normal liver has a relatively low phosphorylation rate for FDG along with high levels of glucose-6-phosphatase, an enzyme that effectively kicks free FDG back out of hepatocytes before it gets trapped. Dynamic PET studies have shown that after an initial burst of FDG entering the liver, the tracer clears relatively quickly because of this enzymatic back-door.27Journal of Nuclear Medicine. Quantification of [18F]FDG Uptake in the Normal Liver Using Dynamic PET: Impact and Modeling of the Dual Hepatic Blood Supply DOTATATE, by contrast, binds to somatostatin receptors that are expressed in liver tissue, which is why the liver lights up more brightly with that tracer. The point is that “normal liver SUV” is meaningless without specifying the tracer.
Automated Measurement and Where the Field Is Heading
How you draw the measurement region on the liver affects the number you get. Traditionally, a radiologist or technologist manually places a region of interest in the right lobe, away from large blood vessels, the dome (where breathing artifacts concentrate), and any visible lesions. Newer deep-learning tools can segment the liver automatically from the CT portion of the scan. One evaluation found that a CT-based deep-learning method produced liver SUVmean measurements with a small bias of about 0.06 g/mL and consistency comparable to manual volume-of-interest approaches, while outperforming atlas-based automatic methods.28Biomedical Physics & Engineering Express. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [18F]FDG PET-CT images
For response-assessment scoring systems like the quantitative Deauville method, using the mean SUV of a standardized liver volume rather than the maximum value is preferred. Maximum SUV is noisier and more sensitive to reconstruction parameters, while mean SUV measured over a consistent volume reduces variance in the final ratio.1Journal of Nuclear Medicine. Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET–Based Response Assessment: Data from the EuroNet-PHL-C1 Trial As automated segmentation becomes more reliable, the hope is that liver reference measurements will become more standardized across centers, reducing one of the persistent sources of variability in PET-based treatment monitoring. For now, if you are getting scans at different facilities, your physicians should ideally know which scanner and reconstruction settings were used at each site so they can interpret changes in SUV with that context in mind.